Olema Pharmaceuticals Inc... (OLMA)
NASDAQ: OLMA
· Real-Time Price · USD
8.31
1.96 (30.87%)
At close: Sep 05, 2025, 3:59 PM
8.54
2.77%
After-hours: Sep 05, 2025, 07:56 PM EDT
30.87% (1D)
| Bid | 8 |
| Market Cap | 570.35M |
| Revenue (ttm) | 364K |
| Net Income (ttm) | -142.29M |
| EPS (ttm) | -1.99 |
| PE Ratio (ttm) | -4.18 |
| Forward PE | -2.94 |
| Analyst | Buy |
| Ask | 8.64 |
| Volume | 3,807,050 |
| Avg. Volume (20D) | 684,683 |
| Open | 6.35 |
| Previous Close | 6.35 |
| Day's Range | 6.35 - 8.43 |
| 52-Week Range | 2.86 - 13.93 |
| Beta | 1.93 |
About OLMA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OLMA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OLMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+16.19%
Olema Pharmaceuticals shares are trading higher. T...
Unlock content with
Pro Subscription
9 months ago
+0.89%
Olema Pharmaceutical shares are trading higher after the company announced a new clinical trial collaboration and supply agreement with Novartis for frontline metastatic breast cancer. Also, the company entered into a private placement of common stock worth $250 million.
